Aclaris Therapeutics (ACRS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist

3.820
+0.190+5.23%

Close Nov 27 16:00 ET

3.850
+0.030+0.79%

Post 20:01 ET

408.69MMarket Cap-7346P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswireNov 26 16:30 ET
Aclaris Therapeutics And 2 Other US Penny Stocks To Watch
Yahoo FinanceNov 21 19:04 ET
Cantor Fitzgerald Upgrades Aclaris Therapeutics to Overweight
MT NewswiresNov 21 07:53 ET
Cantor Fitzgerald Upgrades Aclaris Therapeutics(ACRS.US) to Buy Rating
Moomoo NewsNov 20 16:32 ET · Ratings
Aclaris Therapeutics Upgraded to Buy From Hold at Jefferies
Yahoo FinanceNov 20 05:11 ET
Aclaris Therapeutics Upgraded to Buy From Neutral at BTIG
Yahoo FinanceNov 19 21:30 ET

Comments

FarizK

Nov 21 09:17

$Aclaris Therapeutics (ACRS.US)$ im bullish on this as it has the catalyst to go up and its still early days.

Share Your Profit/Loss

hahohaho

Nov 20 08:39

$Aclaris Therapeutics (ACRS.US)$ it drop,should I sell it?

Stock_Drift

Nov 19 14:22

Unusual Volume Ticks. 3:21pm

$Symbotic (SYM.US)$ $S&W Seed (SANW.US)$ $Vroom (VRM.US)$ $Dogwood Therapeutics (DWTX.US)$ $Interactive Strength (TRNR.US)$ $Syros Pharmaceuticals (SYRS.US)$ $SmartKem (SMTK.US)$ $Next Technology (NXTT.US)$ $Aclaris Therapeutics (ACRS.US)$ $Defiance Daily Target 2X Long SMCI ETF (SMCX.US)$ $noco-noco (NCNC.US)$ $Volato Group (SOAR.US)$ $PainReform (PRFX.US)$

The Real Wojak

Nov 19 11:29

Damn

$Aclaris Therapeutics (ACRS.US)$ This looked like one of the best plays for today in premarket and I forgot about it while looking at other stuff…
EASY money smh 🤦‍♂️

Rivera

Nov 19 11:08

Let’s go

$Aclaris Therapeutics (ACRS.US)$

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

ACRS Aclaris Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target